BUNKA CHRISTOPHER 4

What Happened

• Christopher Bunka, a director of Lexaria Bioscience Corp. (LEXX), recorded a disposition coded as a gift of 100,000 common shares on 2026-03-17. The reported price per share was $0.00 and the total transaction value is $0. According to the filing footnote, the shares were gifted back to Lexaria and returned to the company’s treasury.

Key Details

• Transaction date: 2026-03-17; Filing date: 2026-03-18 (appears timely).
• Transaction type: G = Gift; Price per share: $0.00; Total reported value: $0.
• Shares involved: 100,000 gifted and returned to treasury (per footnote F1).
• Shares owned after transaction: Not specified in the filing.
• Footnote: F1 — the 100,000 shares were gifted back to Lexaria Bioscience Corp. and returned to treasury.
• No 10b5-1 plan or tax-withholding note listed; no late filing flag reported.

Context

• Gifts back to the issuing company and return-to-treasury transactions do not provide a clear bullish/bearish signal about an insider’s view of the stock price. They are distinct from sales (which produce cash) and purchases (which can signal confidence).
• For investors, the practical effects may include a reduction in outstanding shares if the company retires or holds the treasury shares, but the filing does not state whether shares were retired or will be reissued.